Company / Inventory
Charles River Laboratories Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$299.1M
FY2025
5-year range
$199.1M / $380.3M
FY2021-FY2025
Trend
+7.4%
vs FY2024
Sector context
#54 of 115
Health Care
What the data says
At $299M, Charles River Laboratories's inventory ranks #54 of 115 in the Health Care sector. Declined from $380M to $299M over the past 2 years.
Based on SEC 10-K filings.
$299M in FY2025 with a 5-year CAGR of +10.0%.
Declined from $380M to $299M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
#54 of 115 in Health CareTop 47% of 115This company $299.1M Sector average $1.4B
▼
-78.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.0%, indicating consistent growth.
- In FY2025, inventory increased 7.4% year-over-year.
- Ranks #54 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $299.1M | +7.4% |
| FY2024 | $278.5M | -26.7% |
| FY2023 | $380.3M | +48.6% |
| FY2022 | $255.8M | +28.5% |
| FY2021 | $199.1M | +7.2% |
| FY2020 | $185.7M | +15.6% |
| FY2019 | $160.7M | +25.6% |
| FY2018 | $127.9M | +11.3% |
| FY2017 | $115.0M | +20.0% |
| FY2016 | $95.8M | +2.2% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026